Prevalence of fibromyalgia: a survey in five European countries

…, K Le Lay, C Taieb, M Matucci-Cerinic - Seminars in arthritis and …, 2010 - Elsevier
OBJECTIVE: A survey was performed in 5 European countries (France, Germany, Italy,
Portugal, and Spain) to estimate the prevalence of fibromyalgia (FM) in the general population. …

Mortality in systemic sclerosis: an international meta-analysis of individual patient data

…, JM Van Laar, NL Verbeet, M Matucci-Cerinic… - The American journal of …, 2005 - Elsevier
PURPOSE: Studies on mortality associated with systemic sclerosis have been limited by
small sample sizes. We aimed to obtain large-scale evidence on survival outcomes and …

COVID-19, immune system response, hyperinflammation and repurposingantirheumatic drugs

…, AA Güler, M Matucci-Cerinic - Turkish journal of medical …, 2020 - journals.tubitak.gov.tr
… The M protein is the most abundant component of the viral envelope. The M protein … The
M protein gives the shape of the virus and promotes the membrane curvature and the virus …

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative

…, M Baron, A Tyndall, M MatucciCerinic… - Arthritis & …, 2013 - Wiley Online Library
Objective The 1980 American College of Rheumatology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

…, P Brooks, A Brown, M MatucciCerinic… - Arthritis & …, 2011 - Wiley Online Library
Objective Remission in rheumatoid arthritis (RA) is an increasingly attainable goal, but there
is no widely used definition of remission that is stringent but achievable and could be …

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist

…, M Mayes, M Matucci Cerinic, M Rainisio… - Arthritis & …, 2004 - Wiley Online Library
Objective Recurrent digital ulcers are a manifestation of vascular disease in patients with
systemic sclerosis (SSc; scleroderma) and lead to pain, impaired function, and tissue loss. We …

Update of EULAR recommendations for the treatment of systemic sclerosis

…, D Khanna, M Matucci-Cerinic… - Annals of the …, 2017 - ard.bmj.com
The aim was to update the 2009 European League against Rheumatism (EULAR)
recommendations for the treatment of systemic sclerosis (SSc), with attention to new therapeutic …

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

…, M Kuwana, Y Allanore, M Matucci-Cerinic… - The Lancet …, 2020 - thelancet.com
Background A phase 2 trial of tocilizumab showed preliminary evidence of efficacy in systemic
sclerosis. We assessed skin fibrosis and systemic sclerosis-associated interstitial lung …

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial

…, MC Vonk, AV Schattenberg, M Matucci-Cerinic… - Jama, 2014 - jamanetwork.com
Importance High-dose immunosuppressive therapy and autologous hematopoietic stem cell
transplantation (HSCT) have shown efficacy in systemic sclerosis in phase 1 and small …

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative

…, SR Johnson, M Baron, A Tyndall, M MatucciCerinic… - 2013 - deepblue.lib.umich.edu
Objective. The 1980 American College of Rheuma-tology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …